The Role of Genetic Factors in the Development of Idiopathic Osteoarthritis of the Knee in the Kazakh Population
NCT ID: NCT05095142
Last Updated: 2023-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2022-03-30
2023-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population
NCT05090618
The Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh Population
NCT05088486
Identification of Genes Predisposing to Atherosclerosis
NCT00059098
Latvian Early Atherosclerosis Registry
NCT06393894
Genetic Epidemiology of CVD Risk Factors
NCT00053521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group:
patients with idiopathic osteoarthritis of the knee
SNP analysis of the DNA
SNP analysis of the DNA obtained from peripheral blood sample
Control group
patients without idiopathic osteoarthritis of the knee
SNP analysis of the DNA
SNP analysis of the DNA obtained from peripheral blood sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SNP analysis of the DNA
SNP analysis of the DNA obtained from peripheral blood sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Representatives of the Kazakh ethnic group up to the 3rd generation;
3. Hereditary history of arthrosis;
4. Persons who are able and willing to provide written informed consent;
Exclusion Criteria
2. Representatives of other ethnic groups;
3. Representatives of the Kazakh ethnic group less than 3 generations;
4. No family history of bilateral idiopathic gonarthrosis;
5. Patients with an acute period of the inflammatory process (laboratory and clinical signs);
6. Persons who, in the opinion of the researcher, are mentally or legally incapacitated, which prevents obtaining informed consent;
7. Pregnant or lactating women;
8. Tuberculosis of any localization in the active phase and in history;
9. Severe and decompensated diseases of the liver and kidneys, cardiovascular system;
10. Severe and decompensated course of endocrine diseases;
11. Autoimmune diseases;
12. Systemic diseases;
13. Oncological diseases;
18 Years
68 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asfendiyarov Kazakh National Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ildar Fakhradiyev
Head of the Laboratory of Experimental Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olzhas Bekarisov, PhD
Role: PRINCIPAL_INVESTIGATOR
Scientific center of traumatology and orthopedics named after academician Batpenova ND
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scientific center of traumatology and orthopedics named after academician Batpenova ND
Almaty, , Kazakhstan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1191
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.